TEL/ETV6 induces apoptosis in 32D cells through p53-dependent pathways

Biochemical and Biophysical Research Communications

Volumn 347, Issue 2, 2006, Pages 517-526

  Yamagata, Tetsuya ^a   Maki, Kazuhiro ^a   Waga, Kazuo ^a   Mitani, Kinuko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

32D; Apoptosis; ETS; Granulocyte colony stimulating factor; Mitochondria; p21; p53; Pifithrin ; Puma; TEL; Transcription factor

Indexed keywords

COMPLEMENTARY DNA; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; PROTEIN; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BENZOTHIAZOLES; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIAZOLES; TOLUENE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33745878258     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.127     Document Type: Article

References (41)

1. Golub T.R., Barker G.F., Lovett M., and Gilliland D.G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77 (1994) 307-316
2. Poirel H., Oury C., Carron C., Duprez E., Laabi Y., Tsapis A., Romana S.P., Mauchauffe M., Le Coniat M., Berger R., Ghysdael J., and Bernard O.A. The TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene 14 (1997) 349-357
3. Lopez R.G., Carron C., Oury C., Gardellin P., Bernard O., and Ghysdael J. TEL is a sequence-specific transcriptional repressor. J. Biol. Chem. 274 (1999) 30132-30138
4. Kim C.A., Phillips M.L., Kim W., Gingery M., Tran H.H., Robinson M.A., Faham S., and Bowie J.U. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J. 20 (2001) 4173-4182
5. Kwiatkowski B.A., Bastian L.S., Bauer T.R., Tsai J.S., Zielinska-Kwiatkowska A.G., and Hickstein D.D. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J. Biol. Chem. 273 (1998) 17525-17530
6. Potter M.D., Buijs A., Kreider B., van Rompaey L., and Grosveld G. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6. Blood 95 (2000) 3341-3348
7. Wang L., and Hiebert S.W. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene 20 (2001) 3716-3725
8. Martinez R., and Golub T.R. Transcriptional repression of ID1 by the leukemogenic ETS protein TEL. Blood 96 (2000) 453a
9. Fenrick R., Wang L., Nip J., Amann J.M., Rooney R.J., Walker-Daniels J., Crawford H.C., Hulboy D.L., Kinch M.S., Matrisian L.M., and Hiebert S.W. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol. Cell. Biol. 20 (2000) 5828-5839
10. Irvin B.J., Wood L.D., Wang L., Fenrick R., Sansam C.G., Packham G., Kinch M., Yang E., and Hiebert S.W. TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL. J. Biol. Chem. 278 (2003) 46378-46386
11. Arai H., Maki K., Waga K., Sasaki K., Nakamura Y., Imai Y., Kurokawa M., Hirai H., and Mitani K. Functional regulation of TEL by p38-induced phosphorylation. Biochem. Biophys. Res. Commun. 299 (2002) 116-125
12. Maki K., Arai H., Waga K., Sasaki K., Nakamura F., Imai Y., Kurokawa M., Hirai H., and Mitani K. Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol. Cell. Biol. 24 (2004) 3227-3237
13. Wang L.C., Kuo F., Fujiwara Y., Gilliland D.G., Golub T.R., and Orkin S.H. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16 (1997) 4374-4383
14. Wang L.C., Swat W., Fujiwara Y., Davidson L., Visvader J., Kuo F., Alt F.W., Gilliland D.G., Golub T.R., and Orkin S.H. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 12 (1998) 2392-2402
15. Hock H., Meade E., Medeiros S., Schindler J.W., Valk P.J., Fujiwara Y., and Orkin S.H. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev. 18 (2004) 2336-2341
16. Waga K., Nakamura Y., Maki K., Arai H., Yamagata T., Sasaki K., Kurokawa M., Hirai H., and Mitani K. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. Oncogene 22 (2003) 59-68
17. Takahashi W., Sasaki K., Komatu N., and Mitani K. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM. Cancer Sci. 96 (2005) 340-348
18. Rompaey L.V., Potter M., Adams C., and Grosveld G. Tel induces a G1 arrest and suppresses Ras-induced transformation. Oncogene 19 (2000) 5244-5250
19. Migliaccio G., Migliaccio A.R., Kreider B.L., Rovera G., and Adamson J.W. Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J. Cell. Biol. 109 (1989) 833-841
20. Kern S.E., Kinzler K.W., Bruskin A., Jarosz D., Friedman P., Prives C., and Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science 252 (1991) 1708-1711
21. Maki K., Mitani K., Yamagata T., Kurokawa M., Kanda Y., Yazaki Y., and Hirai H. Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia. Blood 93 (1999) 3216-3224
22. Salvioli S., Ardizzoni A., Franceschi C., and Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 411 (1997) 77-82
23. Haris S.L., and Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 24 (2005) 2899-2908
24. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., and Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302 (2003) 1036-1038
25. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., and Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285 (1999) 1733-1737
26. Schuler M., and Green D.R. Transcription, apoptosis and p53: catch-22. Trends Genet. 21 (2005) 182-187
27. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., and Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11 (2003) 577-590
28. Sasaki K., Nakamura Y., Maki K., Waga K., Nakamura F., Arai H., Imai Y., Hirai H., and Mitani K. Functional analysis of a dominant-negative DeltaETS TEL/ETV6 isoform. Biochem. Biophys. Res. Commun. 317 (2004) 1128-1137
29. Tujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J. Cell Physiol. 195 (2003) 158-167
30. Korsmeyer S.J. BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59 (1999) 1693-1700
31. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., and Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352 (1991) 345-347
32. Tuck S.P., and Crawford L. Characterization of the human p53 gene promoter. Mol. Cell. Biol. 9 (1989) 2163-2172
33. Eguchi M., Eguchi-Ishimae M., Tojo A., Morishita K., Suzuki K., Sato Y., Kudoh S., Tanaka K., Setoyama M., Nagamura F., Asano S., and Kamada N. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 93 (1999) 1355-1363
34. Golub T.R., Goga A., Barker G.F., Afar D.E., McLaughlin J., Bohlander S.K., Rowley J.D., Witte O.N., and Gilliland D.G. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16 (1996) 4107-4116
35. Kuno Y., Abe A., Emi N., Iida M., Yokozawa T., Towatari M., Tanimoto M., and Saito H. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood 97 (2001) 1050-1055
36. Hiebert S.W., Sun W., Davis J.N., Golub T., Shurtleff S., Buijs A., Downing J.R., Grosveld G., Roussell M.F., Gilliland D.G., Lenny N., and Meyers S. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16 (1996) 1349-1355
37. Fears S., Gavin M., Zhang D.E., Hetherington C., Ben-David Y., Rowley J.D., and Nucifora G. Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. Proc. Natl. Acad. Sci. USA 94 (1997) 1949-1954
38. Gunji H., Waga K., Nakamura F., Maki K., Sasaki K., Nakamura Y., and Mitani K. TEL/AML1 shows dominant-negative effects over TEL as well as AML1. Biochem. Biophys. Res. Commun. 322 (2004) 623-630
39. Iijima Y., Ito T., Oikawa T., Eguchi M., Eguchi-Ishimae M., Kamada N., Kishi K., Asano S., Sakaki Y., and Sato Y. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood 95 (2000) 2126-2131
40. Salomon-Nguyen F., Della-Valle V., Mauchauffe M., Busson-Le Coniat M., Ghysdael J., Berger R., and Bernard O.A. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc. Natl. Acad. Sci. USA 97 (2000) 6757-6762
41. Nakamura F., Nakamura Y., Maki K., Sato Y., and Mitani K. Cloning and characterization of a novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13). Cancer Res. 65 (2005) 6612-6621